It is regulated by phosphorylation, ubiquitination, and acetylation; the latter is modulated by SIRT1, which deacetylates p65 to inhibit its activity and control the exacerbation of inflammation, offering a therapeutic avenue in diseases such as diabetes, atherosclerosis, and cancer (Das et al., 2025). Here, SIRT1 is linked to cancer.